SCHEMBL14701546

SCHEMBL14701546

COC(=O)c1cc(C)cc(-n2c(C)ccc2C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 2/20 0.54
MYC P01106 3/20 0.53
ALDH1A1 P00352 7/20 0.52
KDM4E B2RXH2 7/20 0.48
HPGD P15428 3/20 0.48
PKM P14618 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TDP1 Q9NUW8 4/20 0.47
POLB P06746 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
USP2 O75604 1/20 0.46
HSPA1A P0DMV8 1/20 0.46
ALOX15 P16050 1/20 0.46
PTPN7 P35236 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7737462 0.91 NR4A1 (0.65) NR4A1MYCALDH1A1KDM4EHPGD
SCHEMBL15714711 0.79 ALDH1A1 (0.69) MYCALDH1A1KDM4EHPGDPKM
Methyl 3,5-Dimethylbenzoate SCHEMBL334346 0.78 CNR2 (0.66) ALDH1A1KDM4ETDP1POLBMAPT
SCHEMBL70232 0.78 ATM (0.61) ALDH1A1KDM4ETDP1POLBMAPT
SCHEMBL5786005 0.76 MYC (0.47) NR4A1MYCALDH1A1KDM4EHPGD
SCHEMBL11362015 0.76 MYC (0.56) MYCALDH1A1KDM4EHPGDPKM
SCHEMBL18617350 0.75 ALDH1A1 (0.49) MYCALDH1A1KDM4EHPGDPKM
SCHEMBL31401209 0.72 TP53 (0.66) ALDH1A1KDM4EHPGDMAPTMEN1
Methyl 3,5-Dimethylbenzoate SCHEMBL9579696 0.72 TSHR (0.73) ALDH1A1KDM4EHPGDTDP1POLB
SCHEMBL19386238 0.71 LMNA (0.47) ALDH1A1KDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8932842-B2 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition NORTHWESTERN UNIVERSITY (US) 2015-01-13 US disclosed
US-20130040359-A1 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition NORTHWESTERN UNIVERSITY (US) 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130040359-A1 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition NOS2, NOS1, NOS3 NR4A1 2210/4885MYC 3787/4885ALDH1A1 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.